Exclusive: Apollo, Sixth Street no longer in talks to finance Twitter deal, sources say

NEW YORK, Oct 5 (Reuters) – Apollo Global Management Inc (APO.N) and Sixth Street, which were looking to provide financing to Elon Musk earlier this year for his proposed buyout of Twitter Inc (TWTR.N), are no longer in talks with the billionaire entrepreneur, according to two sources familiar with the matter. Musk and Twitter are … Read more

Cano Health exploring sale after receiving buyout interest

Register now for FREE unlimited access to Reuters.com Register Sept 22 (Reuters) – US primary care provider Cano Health is exploring a sale and working with advisors after receiving acquisition interest, according to people familiar with the matter. Cano Health has received buyout interest from potential buyers including Humana Inc and CVS Health Corp (CVS.N), … Read more

Novartis to prioritize US market unfazed by drug pricing pushback

Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo Register now for FREE unlimited access to Reuters.com Register ZURICH, Sept 22 (Reuters) – Swiss pharma giant Novartis (NOVN.S) said it would make growth in the United States its top geographic … Read more

Dozen of child deaths prompt Gambia to suspend paracetamol syrup sales

Register now for FREE unlimited access to Reuters.com Register BANJUL, Sept 13 (Reuters) – Gambia on Tuesday ordered importers and shops to suspend sales of all brands of paracetamol syrup while the government investigates a suspected link between the medicine and the deaths of dozens of young children. Last Thursday, the head of the West … Read more

Novartis to spin off generics business Sandoz next year

Co has not received formal offers for Sandoz to date Announcement of spin-off not a surprise – analysts Novartis shares inch up about 1% in morning trading ZURICH/LONDON, Aug 25 (Reuters) – Novartis (NOVN.S) plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines, the Swiss group said … Read more

AstraZeneca’s Soriot warns new US drug price law will hurt innovation

The logo for AstraZeneca is seen outside its North American headquarters in Wilmington, Delaware, US, March 22, 2021. REUTERS/Rachel Wisniewski/File Photo Register now for FREE unlimited access to Reuters.com Register LONDON, Aug 23 (Reuters) – AstraZeneca’s (AZN.L) Chief Executive Pascal Soriot warned on Tuesday new US legislation capping drug prices would reduce the ability of … Read more

Major Gulf markets dip on oil weakness, inflation worries

Traders wait at the Bahrain Bourse after Joe Biden won the US presidency, in Manama, Bahrain, November 8, 2020. REUTERS/Hamad I Mohammed Register now for FREE unlimited access to Reuters.com Register Aug 21 (Reuters) – Most major Gulf stock markets fell on Sunday amid fears of a potential global recession and volatile oil prices, but … Read more

Axsome’s depression drug enters competitive market after US approval

Aug 19 (Reuters) – Axsome Therapeutics Inc (AXSM.O) on Friday gained US approval for its treatment for depression, giving more than 20 million Americans affected by the disorder a new option in a market crowded by older drugs. Shares of the US-based company, which expects to launch the drug in the fourth quarter, surged 25% … Read more

Bayer welcomes ruling against BASF claim on seed businesses

The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo Register now for FREE unlimited access to Reuters.com Register BERLIN, Aug 12 (Reuters) – Bayer (BAYGn.DE) on Friday welcomed a decision by an arbitration court … Read more

J&J to end global sales of talc-based baby powder

Aug 11 (Reuters) – Johnson & Johnson ( JNJ.N ) will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits. “As part of a worldwide portfolio assessment, we have made the commercial … Read more